{"id":"W4281673499","doi":"10.1200/jco.2022.40.16_suppl.e21506","title":"Literature on target therapy of malignant melanoma.","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Fraser Health; Providence Health Care","funders":"","keywords":"Medicine; Ipilimumab; Nivolumab; Dacarbazine; Oncology; Internal medicine; Combination therapy; Melanoma; Carboplatin; Bevacizumab; Dysgeusia; Mucosal melanoma; Immunotherapy; Surgery; Chemotherapy; Cancer; Adverse effect; Cancer research; Cisplatin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004897808,0.0006309493,0.0009800331,0.003843734,0.000276361,0.001034177,0.0009240484,0.001391797,0.0449985],"category_scores_gemma":[0.001529105,0.0001758081,0.000768547,0.004125173,0.0002860462,0.001009462,0.0006331707,0.001294521,0.02141321],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006268334,"about_ca_system_score_gemma":0.001158402,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001052579,"about_ca_topic_score_gemma":0.002368262,"domain_scores_codex":[0.9995742,0.0001035377,0.0001007466,0.00004845717,0.0001426212,0.00003041234],"domain_scores_gemma":[0.999231,0.0002765788,0.0001721706,0.00003346601,0.0002145035,0.00007227418],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002585361,0.00008592771,0.0002999652,0.02526618,0.0001231449,0.0005715963,0.00005369983,0.0001558179,0.0009912811,0.002062667,0.1560902,0.814041],"study_design_scores_gemma":[0.00005550512,0.0000883187,0.0008182904,0.007865303,0.0001381206,0.001723548,0.00002384306,0.00002946228,0.0001785569,0.000717581,0.9883552,0.000006337834],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0004986455,0.9589863,0.0002611951,0.002341593,0.003967175,0.00005849621,0.0007238976,0.0000517728,0.03311082],"genre_scores_gemma":[0.003342256,0.9733078,0.0004818283,0.005571562,0.002859101,0.00006330885,0.001591321,0.00002425755,0.01275861],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.0449985,"threshold_uncertainty_score":0.150535,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0987984687595069,"score_gpt":0.4408057179688073,"score_spread":0.3420072492093004,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}